- Filed
- Aug 7, 2020 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q2 2020 · Jul 31, 2020 | 83.02M sh |
| Total Liabilities | Q2 2020 · Jun 30, 2020 | $1.6B |
| Total Liabilities | Q2 2020 · Dec 31, 2019 | $1.92B |
| Total Assets | Q2 2020 · Jun 30, 2020 | $1.86B |
| Total Assets | Q2 2020 · Dec 31, 2019 | $2.19B |
| Operating Income | Q2 2020 · Jun 30, 2020 | $35.77M |
| Operating Income | Q2 2020 · Jun 30, 2020 | $71.3M |
| Operating Income restated | Q2 2020 · Jun 30, 2019 | $35.71M |
| Operating Income restated | Q2 2020 · Jun 30, 2019 | $70.1M |
| Shares Diluted | Q2 2020 · Jun 30, 2019 | 82.21M sh |
| Shares Diluted | Q2 2020 · Jun 30, 2019 | 82.21M sh |
| Dividends Paid | Q2 2020 · Jun 30, 2019 | $21.38M |
| Capex restated | Q2 2020 · Jun 30, 2019 | $10.13M |
| Operating Cash Flow | Q2 2020 · Jun 30, 2019 | $4.87M |
| Cash And Equivalents | Q2 2020 · Jun 30, 2019 | $35.4M |
| Cash And Equivalents | Q2 2020 · Dec 31, 2018 | $72.42M |
| Stockholders Equity | Q2 2020 · Jun 30, 2019 | $233.88M |
| Stockholders Equity | Q2 2020 · Mar 31, 2019 | $260.59M |
| Stockholders Equity | Q2 2020 · Dec 31, 2018 | $282.45M |
| Eps Diluted | Q2 2020 · Jun 30, 2019 | −$0.12 |
| Eps Diluted | Q2 2020 · Jun 30, 2019 | −$0.27 |
| Eps Basic | Q2 2020 · Jun 30, 2019 | −$0.12 |
| Eps Basic | Q2 2020 · Jun 30, 2019 | −$0.27 |
| Sga Expense restated | Q2 2020 · Jun 30, 2019 | $5.36M |
| Sga Expense restated | Q2 2020 · Jun 30, 2019 | $10.34M |
| Net Income | Q2 2020 · Jun 30, 2019 | −$9.59M |
| Net Income | Q2 2020 · Jun 30, 2019 | −$20.78M |
| Revenue restated | Q2 2020 · Jun 30, 2019 | $86.4M |
| Revenue restated | Q2 2020 · Jun 30, 2019 | $173.74M |